AZN vs. REGN: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AZN and REGN, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
AZN dominates in value with a market cap of 432.07 billion USD, eclipsing REGN’s 64.18 billion USD by roughly 6.73×.
REGN carries a higher beta at 0.43, indicating it’s more sensitive to market moves, while AZN remains steadier at 0.18.
AZN trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while REGN remains a standard domestic listing.
| Symbol | AZN | REGN |
|---|---|---|
| Company Name | AstraZeneca PLC | Regeneron Pharmaceuticals, Inc. |
| Country | GB | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Biotechnology |
| CEO | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. | Dr. Leonard S. Schleifer M.D., Ph.D. |
| Price | 69.68 USD | 604.62 USD |
| Market Cap | 432.07 billion USD | 64.18 billion USD |
| Beta | 0.18 | 0.43 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | May 12, 1993 | April 2, 1991 |
| ADR | Yes | No |
Performance Comparison
This chart compares the performance of AZN and REGN over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AZN and REGN, please refer to the table below.
| Symbol | AZN | REGN |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 27.80 | 14.34 |
| Forward PEG Ratio (TTM) | 2.50 | 1.09 |
| Price-to-Sales Ratio (P/S, TTM) | 3.93 | 4.56 |
| Price-to-Book Ratio (P/B, TTM) | 5.26 | 2.20 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 22.33 | 21.25 |
| EV-to-EBITDA (TTM) | 13.68 | 12.81 |
| EV-to-Sales (TTM) | 4.41 | 4.53 |
| EV-to-Free Cash Flow (TTM) | 25.07 | 21.12 |
Dividend Comparison
AZN’s dividend yield of 1.39% is about 377% higher than REGN’s 0.29%, underscoring its stronger focus on returning cash to shareholders.
| Symbol | AZN | REGN |
|---|---|---|
| Dividend Yield (TTM) | 1.39% | 0.29% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AZN and REGN, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- AZN’s current ratio of 0.90 signals a possible liquidity squeeze, while REGN at 4.93 comfortably covers its short-term obligations.
- AZN’s quick ratio of 0.70 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas REGN at 4.03 maintains a comfortable buffer of liquid assets.
| Symbol | AZN | REGN |
|---|---|---|
| Current Ratio (TTM) | 0.90 | 4.93 |
| Quick Ratio (TTM) | 0.70 | 4.03 |
| Debt-to-Equity Ratio (TTM) | 0.77 | 0.09 |
| Debt-to-Assets Ratio (TTM) | 0.30 | 0.07 |
| Interest Coverage Ratio (TTM) | 7.95 | 98.59 |